Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 110

Adagene advances to IPO

WuXi AppTec and New World Development-backed Adagene has raised close to $140m in its initial public offering after having secured $155m in equity financing.

Feb 17, 2021

Owlet grows into public company

Amazon-backed Owlet Baby Care has agreed to a reverse merger with special purpose acquisition company Sandbridge for a post-deal valuation of $1.39bn.

Feb 17, 2021

KreditBee banks on $75m round

The round consisted of a primary and secondary transaction and the latter allowed Xiaomi to fully exit the company and Kunlun to reduce its shareholding.

Feb 16, 2021

Kokuyo gets Clear in acquisition

Asahi Shimbun, Dentsu and Zoshinkai are set to exit the notebook-sharing platform operator in an acquisition of undisclosed size by office products supplier Kokuyo.

Feb 16, 2021

Pola Orbis makes up Tricot in acquisition

The skincare product maker has agreed to pay $36.2m to acquire the customisable beauty supplement provider, having backed the company in 2019.

Feb 16, 2021

Talis takes in IPO proceeds

Caltech spinout Talis Biomedical has raised more than $220m in an initial public offering on the Nasdaq Global Market.

Feb 16, 2021

LiveRamp acquires DataFleets

LG makes a quick exit after joining DataFleets' $4.5m seed round in October.

Feb 16, 2021

BorgWarner bags Akasol

TU Darmstadt spinout Akasol had floated on the Frankfurt Stock Exchange in 2018 and has now agreed to an acquisition by BorgWarner.

Feb 15, 2021

NexImmune collects IPO proceeds

NexImmune priced shares at $17 to raise $110m in an upsized offering, enabling Amgen and Pfizer to exit the Johns Hopkins University spinout.

Feb 15, 2021

Decibel resonates with public markets

The hearing loss treatment developer has raised more than $127m in its initial public offering that offered exits to Alphabet, GlaxoSmithKline and Regeneron.

Feb 15, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here